LONDON, July 26, 2026, 19:29 BST — Market has closed.
- HSBC stock climbed 4.1% over the past week, closing Friday at 1,552.8p following a 1.7% increase.
- The S$2.7 billion sale of the insurer represents 22.9 times the subsidiary’s projected 2025 pretax earnings. HSBC will maintain a 15-year distribution agreement.
- Initial estimates indicate CET1 for the second quarter is at 14.2%, and project the share count in 2026 will be 1.3% lower.
HSBC’s departure from Singapore makes its August 4 results a measure of capital return. The lender is divesting underwriting risk at a high multiple, while retaining its customer interface.
The sale does not resolve the immediate buyback issue. The CET1 gain will be realised only once the deal closes, which is anticipated in the first half of 2027.
Organic capital is the initial priority. HSBC stated that buybacks will not restart before CET1 reaches the 14%-14.5% target band. Early consensus for the second quarter puts it at 14.2%.
The consensus also provides a clearer signal. Basic shares are projected at 17.17 billion in the second quarter, dropping to 16.95 billion by 2026. The difference amounts to 220 million shares, representing 1.3%.
The difference, based on Friday’s share price, equates to around £3.4 billion. This figure reflects analyst expectations and does not represent official HSBC buyback guidance. Factors such as employee share plans and additional capital initiatives can also impact the total.
HSBC has reached a deal to sell HSBC Life Singapore to Allianz ETR:ALV for S$2.7 billion. In addition, Allianz will pay S$200 million for 15-year exclusive distribution rights.
Based on the published transaction data alongside HSBC’s initial consensus from 18 analysts, the principal comparisons are as follows:
| Measure | Comparison | Investor read-through |
|---|---|---|
| Equity price to 2025 unit PBT | S$2.7bn / S$118m = 22.9 times | Elevated exit multiple |
| CET1, Q1 actual against Q2 preliminary | 14.0% / 14.2% | Increase of 20 basis points; stays within target range |
| Basic shares, Q2 to 2026 preliminary | 17.17bn / 16.95bn = down 1.3% | Difference is about £3.4bn at Friday’s share price |
| Disposal gain to preliminary Q2 PBT | US$1.8bn / US$9.508bn = 18.9% | Significant, but majority recognised in 2027 |
The valuation stands out. HSBC Life Singapore reported a pre-tax profit of S$118 million in 2025, putting the equity sale multiple at 22.9 times earnings.
Allianz maintains its forecast for a double-digit return in the midterm. For HSBC investors, the agreement sheds underwriting that requires capital but keeps open the ability to offer insurance products.
The fee will be recognized gradually. HSBC is set to account for the S$200 million payment throughout the 15-year period, in addition to variable performance-based payments.
HSBC anticipates recording the majority of the US$1.8 billion accounting gain upon completion, designating it as a significant notable item. This amount will not be included in the regular dividend payout calculation.
Ralph Chen, senior analyst at S&P Global Market Intelligence NYSE:SPGI, stated that the sale was “expected to enhance the capital positions of the bank with a higher CET1 ratio.” He noted that the extra capital has the potential to fund buybacks, a special dividend or expansion. Reuters
Analysts’ preliminary consensus estimates project pretax profit for the second quarter at US$9.508 billion and revenue at US$18.570 billion. In the first quarter, pretax profit reached US$9.4 billion, and CET1 stood at 14.0%.
The stock climbed 4.1% over the past week. On Friday, a 1.7% increase outperformed the FTSE 100, which added 0.9% as the index recorded its second consecutive weekly gain.
HSBC acquired AXA (EPA:CS)’s Singapore business for US$529 million in 2022. The latest sale involves HSBC’s larger, more comprehensive local insurance unit, meaning it does not represent a straightforward fourfold profit.
The July 27-31 trading week marks the last complete week ahead of results. HSBC is scheduled to report on Tuesday, August 4, at 5 a.m. BST. Investors are set to monitor CET1, any buyback announcement, Banking NII, and credit expenses.
Risks: The deal awaits clearance from the Monetary Authority of Singapore. Completion may be delayed past the first half of 2027. The projected 15-basis-point increase is a forecast, and rising credit costs could use up capital.
A CET1 figure of 14.2% would reinforce the case for a buyback. If the ratio falls short of 14%, the buyback would be postponed, no matter the outcome of the Singapore agreement.
